{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:39:05Z","timestamp":1791265145297,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"DOI":"10.7759\/cureus.98542","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:33:01Z","timestamp":1764973981000},"source":"Crossref","is-referenced-by-count":2,"title":["Choroidal Detachment Secondary to Scleral Wound Leak After Ozurdex\u00ae Implantation in an Eye With Previous Vitrectomy: A Case Report"],"prefix":"10.7759","author":[{"given":"Sajad","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawaja R","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000494224","article-title":"Prevalence of retinal vein occlusion in Europe: A systematic review and meta-analysis","volume":"241","author":"Li JQ","year":"2019","unstructured":"Li JQ, Terheyden JH, Welchowski T, et al.. Prevalence of retinal vein occlusion in Europe: A systematic review and meta-analysis. Ophthalmologica. 2019, 241:183-9. 10.1159\/000494224","journal-title":"Ophthalmologica"},{"key":"ref2","unstructured":"U.S. Food and Drug Administration. Ozurdex\u00ae (Dexamethasone Intravitreal Implant) Prescribing Information. (2022). https.\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/022315Orig1s016lbl.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller JA","year":"2010","unstructured":"Haller JA, Bandello F, Belfort R Jr, et al.. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010, 117:1134-1146.e3. 10.1016\/j.ophtha.2010.03.032","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder C","year":"2011","unstructured":"Lowder C, Belfort R Jr, Lightman S, et al.. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011, 129:545-53. 10.1001\/archophthalmol.2010.339","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318206d18c","article-title":"Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients","volume":"31","author":"Boyer DS","year":"2011","unstructured":"Boyer DS, Faber D, Gupta S, et al.. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011, 31:915-23. 10.1097\/IAE.0b013e318206d18c","journal-title":"Retina"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31827e247b","article-title":"Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients","volume":"33","author":"Ad\u00e1n A","year":"2013","unstructured":"Ad\u00e1n A, Pelegr\u00edn L, Rey A, et al.. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Retina. 2013, 33:1435-40. 10.1097\/IAE.0b013e31827e247b","journal-title":"Retina"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001364","article-title":"Ocular hypertension after intravitreal dexamethasone (Ozurdex) sustained-release implant","volume":"37","author":"Chin EK","year":"2017","unstructured":"Chin EK, Almeida DR, Velez G, et al.. Ocular hypertension after intravitreal dexamethasone (Ozurdex) sustained-release implant. Retina. 2017, 37:1345-51. 10.1097\/IAE.0000000000001364","journal-title":"Retina"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7817542","article-title":"Intravitreal injections for macular edema secondary to retinal vein occlusion: Long-term functional and anatomic outcomes","volume":"2020","author":"Maggio E","year":"2020","unstructured":"Maggio E, Mete M, Maraone G, Attanasio M, Guerriero M, Pertile G. Intravitreal injections for macular edema secondary to retinal vein occlusion: Long-term functional and anatomic outcomes. J Ophthalmol. 2020, 2020:7817542. 10.1155\/2020\/7817542","journal-title":"J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000452896","article-title":"Long-term real-life efficacy and safety of repeated Ozurdex\u00ae injections and factors associated with macular edema resolution after retinal vein occlusion: The REMIDO 2 Study","volume":"236","author":"Pommier S","year":"2016","unstructured":"Pommier S, Meyer F, Guigou S, et al.. Long-term real-life efficacy and safety of repeated Ozurdex\u00ae injections and factors associated with macular edema resolution after retinal vein occlusion: The REMIDO 2 Study. Ophthalmologica. 2016, 236:186-92. 10.1159\/000452896","journal-title":"Ophthalmologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2017.06.31","article-title":"Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye","volume":"10","author":"Lee SM","year":"2017","unstructured":"Lee SM, Jung JW, Park SW, Lee JE, Byon IS. Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye. Int J Ophthalmol. 2017, 10:1019-20. 10.18240\/ijo.2017.06.31","journal-title":"Int J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-16204","article-title":"Scleral thinning after repeated intravitreal injections of antivascular endothelial growth factor agents in the same quadrant","volume":"56","author":"Zinkernagel MS","year":"2015","unstructured":"Zinkernagel MS, Schorno P, Ebneter A, Wolf S. Scleral thinning after repeated intravitreal injections of antivascular endothelial growth factor agents in the same quadrant. Invest Ophthalmol Vis Sci. 2015, 56:1894-900. 10.1167\/iovs.14-16204","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson PG","year":"1976","unstructured":"Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976, 60:163-91. 10.1136\/bjo.60.3.163","journal-title":"Br J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat KM","year":"2010","unstructured":"Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol. 2010, 21:178-83. 10.1097\/ICU.0b013e328338679a","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441525-choroidal-detachment-secondary-to-scleral-wound-leak-after-ozurdex-implantation-in-an-eye-with-previous-vitrectomy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:33:06Z","timestamp":1764973986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441525-choroidal-detachment-secondary-to-scleral-wound-leak-after-ozurdex-implantation-in-an-eye-with-previous-vitrectomy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.98542","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}